Therefore, the enhanced anti-oxidative capacity of SOD3-MSCs would upregulate the therapeutic outcome of MSCs application in IBD by potentiating the endogenous regeneration in the intestinal epithelium. Here, SOD3 is linked to inflammatory bowel disease.